I. INTRODUCTION
This paper attempts to provide a systematic overview of the principles and practice of biodosimetry. Biodosimetry is the use of radiation induced changes in the tissues to provide an estimate of the dose the person may have received in a radiation event. Biodosimetry provides an estimate of the individual's risk of developing the life threatening consequences of acute radiation syndrome, which is useful for making the initial decision to triage the person into the medical system for urgent care. For individuals with confirmed evidence of exposure, biodosimetry also can be used in a second stage to provide more refined estimates of dose and may also supply organ-specific information of damage or evidence of whole or partial body exposure, which are useful for deciding the most appropriate timing and type(s) of therapeutic intervention. As both experience and analyses have shown, the dose received by many individuals cannot be reliably determined by other means such as film badge dosimeters or calculations of the dose distribution over the affected area.
We consider three types of scenarios (large scale involving hundreds of thousands of individuals, small scale involving a small number of individuals, and epidemiological studies of the effects of small doses to a large population) in terms of the role that biodosimetry can effectively have to respond effectively to the scenario. We then summarize the characteristics of the various types of types of biodosimetry, and finally relate these characteristics to the needs identified for each type of event.
II. REQUIREMENTS FOR DOSIMETRY FOR VARIOUS TYPES OF RADIATION EVENTS

A. A large scale radiation event
A large-scale radiation event involving hundreds of thousands of individuals such as a major nuclear power plant malfunction or terrorism involving release of radioactive material and/or radiation exposure provides the most compelling need for biodosimetry. This is because of the large discrepancies among the number of people who have a basis for being concerned that they have had a potentially lifethreatening exposure to ionizing radiation (could be more than 1 million individuals), the inability of the health care systems to deal with such large numbers, and the existence of a subset of individuals who would have significant benefit from being treated. The key to appropriate management of such an event is to identify those that would benefit from treatment as efficiently as possible so that only they enter the health care system where they can be more definitively evaluated. The way to do this is to determine the physical exposure dose and its homogeneity. The requirement for biodosimetry for this stage then is to be able to make a rough estimate of dose quickly and in the field. The next stage of triage, where the initial estimate of exposure dose is first verified and then, for those whose exposures warrant treatment, can take place in or near the health care system. These individuals will be able to stay at that site, so the appropriate biodosimetry techniques no longer need to be field deployable or to give immediate results. At this stage techniques that can assess of the homogeneity of the exposure would be very valuable because, if significant amounts of bone marrow received lower doses, the prognosis is significantly better and treatment needs would differ. Also, biodosimetry techniques that can assess the biological impact of the dose would be very useful for determining the urgency and priority for treatment [6, 5, 2] . Following these initial two levels of triage, remaining subjects will undergo intense medical management and the further role of biodosimetry is likely to be limited or not needed.
The desirable characteristics for biodosimetry vary somewhat with the types of large-scale event. If an event does involve many significant exposures, such as would be the case with an improvised nuclear device (IND) detonated in a large urban area, it would be urgent to screen more than a million people quickly [1, 4, 7] to find those who need treatment (including prophylactic treatment, which should be limited to those with significant exposures to avoid a high number of significant toxic events in subjects that did not require treatment). For this situation it will be essential to have biodosimetry that is field deployable, has an integrated and rapid per-sample processing capacity and with immediate readout of a dose estimate suitable for initial triage. In addition to individual estimates, it would be desirable to use appropriate sampling so that groups of individuals in a similar location can be triaged based on measurements made in only a few.
On the other hand in some instances, such as the nuclear power plant accident that occurred in Fukushima, Japan in 2011, the number of life-threatening exposures may be known to be very likely to be absent or small so that urgent triage decisions are not necessary. Nonetheless, there may still be a need for measurements in a large number of individuals, because of a lack of trust in reassurances from authorities. The situation would be similar for a radiation dispersal device (i.e., a "dirty bomb"), which is more likely to induce fear of exposure rather than true life threatening exposures. For these situations biodosimetry techniques that do not have immediate readout may be quite satisfactory, especially because it would much easier to relocate the measured individual (who can remain at home) unlike the situation after an IND. A radiation exposure device such as a radiation source hidden on a train would similarly result in relatively few life threatening exposures and even less logistical disruption.
B. A small scale radiation event
The requirements for a smaller scale event are quite different in many important ways. Current experience of responders to emergency radiation events is for this type of event and, even though it may be inappropriate to scale-up to thousands of victims, it may have influenced some recommendations for large scale events. Radiation exposures in small accidents are often heterogeneous. Usually the number of individuals involved is sufficiently small that all potentially affected individuals can be entered into the health care system for observation. The principal role that biodosimetry has had in dealing with these events has been to estimate local doses (e.g., to the hand) for very heterogeneous exposures. This type of event also has provided some data on the performance of biodosimetry techniques in human subjects.
C. Epidemiological studies
While the above scenarios concern the acute needs for saving lives of people at risk for acute radiation syndrome, people with low doses may be appropriate to identify for long term surveillance. Biodosimetry results at low levels, while not requiring ARS care, could be retained to aid decisions regarding long term surveillance and quantitative estimates of risk from lower dose of radiation. In addition, the nearby population who may not have been assessed at all in the few days or weeks after the event may present an additional opportunity to evaluate the long term risks from exposures to ionizing radiation. These effects that are especially important to understand include radiationinduced cancer and the induction of deleterious mutations. The requirements for biodosimetry techniques to be able to provide such epidemiological information require characteristics that are different than those needed to determine exposure levels for the acute effects. These include the capability for good resolution of relatively small doses in large numbers of individuals, in order, retrospectively, to relate absorbed dose to long terms effects, especially cancer. Biodosimetry already has had a key role in these studies, providing much or all of the data for this purpose. The requirements for the biodosimetry techniques for this application include remaining valid for many years after the exposure, and being capable of accurately measuring low doses in the range of 0.3 to 1 Gray.
III. THE NATURE OF BIODOSIMETRY
The principle underlying biodosimetry is to utilize changes in the tissues of the individual induced by radiation as a quantitative measure of the amount of radiation that was absorbed [8] . There are potentially many parameters that could be measured [7, 3] . These parameters can be usefully considered as two different potential approaches for biodosimetry: Those that (1) directly measure damage induced by exposure to ionizing radiation, i.e., specifically assess resulting physical changes such as the production of stable free radicals in teeth or unique chemical products such as inert gases that are then released through the lungs and (2) indirectly measure the damage caused by the radiation by assessing instead the biological response to damage, e.g., by upregulation of genes (genomics) or protein products (proteomics), or biologically modified products from the radiation (metabolomics) or changes in hematological parameters (dicentric chromosomes or double strand DNA breaks). Then, via appropriate calibration curves, these responses can be related back to the radiation dose received. As indicated in Fig. 1 the biological responses have time dependent changes in the measured parameters (lower portion of the marker rather than an increase as portrayed).
Fig. 1. TIME COURSE OF PARAMETERS USED FOR BIODOSIMETRY
978-1-5090-0770-7/16/$31.00 ©2016 IEEE Consequently, when using methods that are based on responses to damage rather than directly associated with exposure to ionizing radiation, it is important to keep in mind that these time-dependent changes due to the ionizing radiation damage occur via the same pathways as responses to any other damaging event, i.e., these pathways per se are not specific to ionizing radiation. The upper part of Fig. 1 , in contrast, presents the corresponding time course for changes based on persistent physical changes induced directly by ionizing radiation. Note in the example in Fig. 1 , based on the amount of stable free radicals produced in teeth, that the changes occur virtually instantaneously with the exposure and do not change further (these changes are stable for millions of years). In some physical methods, they can be further modified by biological processes (e.g. bone or fingernails, where the free radicals are lost as the bone remodels or nails regrow) there could be timedependent decreases in the magnitude of the radiation-induced changes, albeit the changes occur slowly over weeks or months post exposure.
The time-dependent changes that are intrinsic to any biological response present some significant challenges in trying to relate them quantitatively to radiation dose. Because these are changes from a baseline, it is unlikely that all subjects will have the same baseline level of the parameter (portrayed as point 1 in Fig. 1 ) that is measured due to physiological variations and prior pathophysiology. If the radiation induced changes are very large compared to the baseline, this will not be a problem in regards to the baseline levels. However, these factors may affect the length of the latent period (period between points 1 & 2) and the rate at which the radiationinduced changes occur (period between points 2 & 3) and also could affect the length of the other two periods (the quasisteady between periods 3 to 4, and the time and extent of the period 4 to 5 when the radiation-induced changes return towards baseline). (Fig. 1 portrays a generic   TABLE I.  TIMES LISTED ARE AFTER THE EXPOSURE TO RADIATION, BASED ON THE CITED REFERENCE biological response; note that such changes from baseline could actually result in a reduction in the amount of the marker rather than an increase as portrayed here.)
An additional potential challenge is the extent to which these time-dependent changes can be affected by simultaneous trauma and stress, factors that are quite probable in the event of a large-scale event. This complexity is exemplified by the fact that there are no good in vivo human models for biological responses, leading to some of the frustrations in the development of biodosimetry based on biological responses. While many human subjects receive large doses via therapeutic irradiation (including some who receive whole body irradiation) and would thus appear to be suitable for testing, the consensus has been that these are not suitable because of serious confounding from responses to the disease for which they are being treated and the impact of their overall compromised medical status. Using irradiated subjects has not been a limitation for EPR tooth dosimetry because the presence of disease does not affect the yield or the stability of the free radicals induced in teeth by ionizing radiation. (This would be similar for other direct approaches such as assessing nails.) The limitations in the use of human subjects for biological response biodosimetry methods has resulted in a high reliance on the use of non-human primates (NHP) for validation of the biological response based measurements in an in vivo model. However, due to the limited number of NHPs available for study and the very different patterns of disease and range of ages that are available (most studies in NHPs have had to use ages that are equivalent to human teenagers or younger), the effects of prior or simultaneous disease and other potential confounders such as smoking and stress have not been extensively studied.
IV. CHARACTERISTICS OF SPECIFIC TYPES OF BIODOSIMETRY IN REGARD TO THE PERIODS OF RESPONSE
Based upon the periods in Fig. 1 [7] , but it should be noted that there is considerable variation in the reported values.
V. CONCLUSIONS
Some general conclusions can be drawn from these limited and representative data. For initial triage in a large-scale event, only those types of measurements that can be done in the field, can provide immediate results, and obtain dose estimates using general calibration curves or simple modifications of them for such factors as gender and age, are likely to be feasible for initial triage (see [7] and its summarization of the US federal targets for biodosimetry methods). For methods that can meet these targeted criteria, methods based on the indirect assessment of the biological responses to radiation damage have additional challenges because of the wide range of possible variations in baseline values due to prior history and the variability of the population in regards to age, etc., and the potential effects of simultaneous stress and trauma. The timedependent responses may be similarly impacted as their rates and extent may be modified. For the second stage of triage, which will take place in an organized although often ad hoc medical facility, techniques with long latent periods and/or with requirements for being processed in specialized labs will become more applicable. In such a more stabilized setting, it also may be more feasible to obtain information on potential confounders such as prior disease and to be able to make repeated measurements to determine if there needs to be a modification of the use the calibration curves.
For small scale incidents in which it is likely that most of the subjects can be placed in regular health care facilities, there are fewer limitations as to which techniques can be used, although it is also true that the importance of biodosimetry is more limited in such circumstances.
For epidemiological studies, because of the requirements for long term validity and resolution of low doses by the biodosimetry techniques (see Table 1 ), only a few techniques are likely to be of value.
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